Inactivated Influenza B Virus Vaccine
DBCAT004010Therapeutic category
A DrugBank category of 13 drugs. 13 of them are approved.
- Part of
- Influenza Vaccines
- Drugs
- Influenza B virus B/Arizona/21/2025 antigen (MDCK cell derived, propiolactone inactivated)
- Influenza B virus B/Austria/1359417/2021 BVR-26 antigen (propiolactone inactivated)
- Influenza B virus B/Austria/1359417/2021 BVR-26 antigen (UV, formaldehyde inactivated)
- Influenza B virus B/Austria/1359417/2021 BVR-26 hemagglutinin antigen (formaldehyde inactivated)
- Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)
- Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)
- Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)
- Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)
- Influenza B virus B/Michigan/01/2021 antigen (formaldehyde inactivated)
- Influenza B virus B/Phuket/3073/2013 antigen (formaldehyde inactivated)
- Influenza B virus B/Singapore/WUH4618/2021 antigen (MDCK cell derived, propiolactone inactivated)
- Influenza B virus B/Tokyo/EIS13-175/2025 antigen (formaldehyde inactivated)
- Influenza B virus B/Tokyo/EIS13-175/2025 antigen (UV, formaldehyde inactivated)
What you can answer from here — as of September 15, 2022
Which Inactivated Influenza B Virus Vaccine are approved where, and how do their indications and safety profiles compare?
Create a free account or log in to explore the full data card.
Create Account